Deirdre Somers - 13 Jan 2025 Form 4 Insider Report for Enfusion, Inc.

Role
Director
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Jan 2025
Net transactions value
-$17,238
Form type
4
Filing time
15 Jan 2025, 17:03:26 UTC
Previous filing
17 Jun 2024
Next filing
21 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Sale $17,238 -1,637 -3.8% $10.53 41,675 13 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares required by the Issuer to be sold by the Reporting Person to cover tax withholding obligations in connection with the issuance of the shares, and does not represent discretionary trades by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.36 to $10.82. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.